ACR 2025 Archives - Medical Conferences

Home > Rheumatology > ACR 2025

Read the full Report (pdf)

American College of Rheumatology Annual Meeting 2025 24-29 October 2025 Chicago, Illinois, USA

Head-to-head trial shows secukinumab superior to ustekinumab in psoriatic arthritis 

Presented By

Prof. Frank Behrens , Fraunhofer Institute for Translational Medicine and Pharmacology, Germany

Conference

ACR 2025

Type

News article

27 November 2025 23:56

IDH1/2 mutations linked to inflammatory and rheumatological disorders

Presented By

Dr Flore Castellan, New York University School of Medicine, NY, USA

Conference

ACR 2025

Type

Peer-reviewed article

27 November 2025 23:49

A joint ASAS/SPARTAN initiative proposes revised diagnostic criteria for axial spondyloarthritis

Presented By

Prof. Walter P. Maksymowych , University of Alberta, AB, Canada

Conference

ACR 2025

Type

News article

27 November 2025 23:16

Online First

Advances in Inflammatory and Degenerative Rheumatic Diseases

Deucravacitinib holds promise for patients with psoriatic arthritis

Presented By

Prof. Philip Mease, Swedish Medical Center, WA, USA

Conference

ACR 2025

Type

Peer-reviewed article

27 November 2025 23:31

Phase 2b data show that rosnilimab is effective in rheumatoid arthritis

Presented By

Prof. Paul Emery , University of Leeds, UK

Conference

ACR 2025

Type

News article

27 November 2025 23:27

A joint ASAS/SPARTAN initiative proposes revised diagnostic criteria for axial spondyloarthritis

Presented By

Prof. Walter P. Maksymowych , University of Alberta, AB, Canada

Conference

ACR 2025

Type

News article

27 November 2025 23:16

LEVI-04 holds potential to be the first disease-modifying therapy for knee osteoarthritis

Presented By

Dr Simon Westbrook , Levicept Ltd, UK

Conference

ACR 2025

Type

News article

27 November 2025 22:59

A urinary tenascin-C biomarker score predicts long-term kidney function in lupus nephritis

Presented By

Dr Andrea Fava , Johns Hopkins University, MD, USA

Conference

ACR 2025

Type

News article

27 November 2025 22:56

GLP-1 receptor agonists may protect against cardiac events in patients with psoriatic arthritis

Presented By

Dr Nanuka Tsibadze , Jefferson Einstein Hospital, PA, USA

Conference

ACR 2025

Type

News article

27 November 2025 22:42

Two-year treatment with upadacitinib shows high remission in patients with giant cell arteritis

Presented By

Prof. Wolfgang Schmidt, Medical Centre for Rheumatology Berlin-Buch, Germany

Conference

ACR 2025

Type

News article

27 November 2025 22:32

Novel Immunotherapies and Targeted Treatments

Telitacicept reveals positive efficacy data in Chinese patients with Sjögren’s disease

Presented By

Dr Dong Xu , Peking Union Medical College Hospital, China

Conference

ACR 2025

Type

News article

27 November 2025 23:48

CAR Treg cells show initial efficacy in hard-to-treat rheumatoid arthritis

Presented By

Dr Minna Kohler , Massachusetts General Hospital, MA, USA

Conference

ACR 2025

Type

News article

27 November 2025 23:37

Phase 3 data reinforce ianalumab activity in Sjögren’s disease

Presented By

Prof. Thomas Grader-Beck , Johns Hopkins University of Medicine, MA, USA

Conference

ACR 2025

Type

News article

27 November 2025 23:33

From Mechanistic Insights to Real-World Practice

Head-to-head trial shows secukinumab superior to ustekinumab in psoriatic arthritis 

Presented By

Prof. Frank Behrens , Fraunhofer Institute for Translational Medicine and Pharmacology, Germany

Conference

ACR 2025

Type

News article

27 November 2025 23:56

Many high-risk post-menopausal women in the USA remain undertreated for osteoporosis

Presented By

Dr Xiaodong Li , Amgen Inc., CA, USA

Conference

ACR 2025

Type

News article

27 November 2025 23:54

Hydroxychloroquine blood level monitoring may reduce toxicity risk in lupus

Presented By

Dr Shivani Garg , University of Wisconsin School of Medicine and Public Health, WI, USA

Conference

ACR 2025

Type

News article

27 November 2025 23:52

NTR-441 is an emerging treatment option for rheumatological conditions

Presented By

Dr Tobias Fuchs , Neutrolis Inc., MA, USA

Conference

ACR 2025

Type

News article

27 November 2025 23:51

IDH1/2 mutations linked to inflammatory and rheumatological disorders

Presented By

Dr Flore Castellan, New York University School of Medicine, NY, USA

Conference

ACR 2025

Type

Peer-reviewed article

27 November 2025 23:49

Medical Conferences

ACR 2025

Featured articles

Head-to-head trial shows secukinumab superior to ustekinumab in psoriatic arthritis

IDH1/2 mutations linked to inflammatory and rheumatological disorders

A joint ASAS/SPARTAN initiative proposes revised diagnostic criteria for axial spondyloarthritis

CONTENTS

Online First

Advances in Inflammatory and Degenerative Rheumatic Diseases

Deucravacitinib holds promise for patients with psoriatic arthritis

Phase 2b data show that rosnilimab is effective in rheumatoid arthritis

A joint ASAS/SPARTAN initiative proposes revised diagnostic criteria for axial spondyloarthritis

LEVI-04 holds potential to be the first disease-modifying therapy for knee osteoarthritis

A urinary tenascin-C biomarker score predicts long-term kidney function in lupus nephritis

GLP-1 receptor agonists may protect against cardiac events in patients with psoriatic arthritis

Two-year treatment with upadacitinib shows high remission in patients with giant cell arteritis

Novel Immunotherapies and Targeted Treatments

Telitacicept reveals positive efficacy data in Chinese patients with Sjögren’s disease

CAR Treg cells show initial efficacy in hard-to-treat rheumatoid arthritis

Phase 3 data reinforce ianalumab activity in Sjögren’s disease

From Mechanistic Insights to Real-World Practice

Head-to-head trial shows secukinumab superior to ustekinumab in psoriatic arthritis

Many high-risk post-menopausal women in the USA remain undertreated for osteoporosis

Hydroxychloroquine blood level monitoring may reduce toxicity risk in lupus

NTR-441 is an emerging treatment option for rheumatological conditions

IDH1/2 mutations linked to inflammatory and rheumatological disorders